老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

0.0622
+0.00233.84%
成交量：10.88萬
成交額：5,821.98
市值：- -
市盈率：- -
高：0.0636
開：0.0632
低：0.0526
收：0.0599
資料載入中...
總覽公司新聞公告
2021/05/07

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/19

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/15

重要事件披露

8-K - Current report
2021/03/24

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

重要事件披露

8-K - Current report
2021/03/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/04

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K/A [Amend] - Current report
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/07

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/18

重要事件披露

8-K - Current report
更多